Displaying items by tag: department of medicine

Heart-healthy recipes have numerous other health benefits as well, such as strengthening gastrointestinal health and lowering blood-sugar and cholesterol levels.
 
UAB infectious diseases expert will discuss mask fit, filtration and effectiveness during the coronavirus pandemic in a free webinar Feb. 17 from noon-1 p.m.
Consortium led by UAB researchers in the UAB Heersink School of Medicine and School of Public Health received additional funding to further study chronic hypertension and preeclampsia epigenetics participants enrolled in the CHAP trial.
The Cardiogenomics Clinic uses a patient’s genetic history to help develop a personalized treatment plan based on their genetic results.
For those who had COVID-19, lingering heart problems can complicate their recovery. UAB experts address common concerns that people have with their heart health after COVID-19.

Collaborative care, reforming payment models, incentivizing primary care and utilizing the digital tools can positively change the landscape of American health care. 

UAB Hospital practice areas were honored with the “Best Hospital” designation, including patient experience, bariatric surgery, obstetrics, minimally invasive surgery, stroke care, cancer care, breast care and women’s services.

The UAB Advanced Limb Preservation Program represents a multidisciplinary collaboration involving numerous fields of study, including vascular surgery, podiatry and wound care. This team focuses on lower extremity limb preservation, diabetic foot care and complex wound management.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

This revitalization kick-off event follows ribbon-cuttings held in two other Live HealthSmart Alabama demonstration communities, Titusville and Kingston, earlier this year. 

UAB’s Know Overdose Initiative seeks to educate, identify and prescribe Naloxone for individuals who have been identified as high risk for overdose.

At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.

Page 10 of 37